Why NuScale Power Stock Jumped Nearly 24% To Start 2026

NuScale Power shares surged 23.4% in January after the Trump administration outlined an aggressive nuclear roadmap (three experimental reactors by July 4, 2026; multiple SMRs by end-2027; nuclear on military bases by 2028) and Bank of America upgraded the stock from Underperform to Neutral with a $28 price target, citing NuScale's NRC-certified SMR design and a TVA licensing agreement. However, the rally cooled after Microsoft's quarterly report revealed $37.5 billion in capex, rattling AI infrastructure demand — a key growth narrative for NuScale — underscoring execution and commercialization risks despite favorable regulatory and political tailwinds.

Analysis

Market structure: NuScale (SMR), TVA contractors, EPC firms and commodity suppliers (uranium, steel, copper) are direct beneficiaries if the White House roadmap accelerates procurement toward 2026–2028; conversely, short-duration beneficiaries of AI hyperscale capex (cloud infra suppliers and semiconductor cyclicals) face re-rating risk if MSFT and peers pull back. Competitive dynamics favor proven light‑water SMR designs (NuScale) over riskier advanced concepts — expect pricing power to be limited by large fixed‑price government contracts and heavy EPC competition.

Risk assessment: Tail risks include regulatory reversal, a failed TVA/DOE financing package, or major construction cost overruns that could wipe out equity (30–70% downside). In days–weeks expect headline volatility; in months licensing and DOE funding decisions (next 3–12 months) will be binary catalysts; in years (2026–2028+) revenue realization hinges on first-of-a-kind builds, supply‑chain big‑forge delivery schedules, and enrichment/fuel supply.

Trade implications: Tactical: small asymmetric exposure to SMR via long-dated calls/LEAPS (12–36 months) sized 1–3% of risk capital, funded by short-dated put spreads on AI‑capex beneficiaries (MSFT/NVDA) to hedge scenario where AI demand softens. Rotate 3–5% from high‑multiple AI infra names into energy infrastructure, uranium miners and select industrials; use option collars to cap downside and monetize near-term volatility.

Contrarian angles: Consensus links NuScale to AI energy demand — that’s narrow. Defense grid resilience mandates and TVA contractor economics can create demand independent of hyperscaler capex; conversely, a political rush could cause poorly executed projects and large write‑downs. The market may be over‑discounting long‑dated execution risk today and under‑pricing multi‑year strategic demand if federal procurement follows through.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in SMR common stock as a high‑risk, long‑dated growth bet; set an initial stop‑loss at 40% below entry and scale to 4–5% only after a confirmed DOE/TVA milestone (firm award or funding tranche) within 90 days.
• Buy SMR 12–36 month LEAPS call options (size = 1–2% of portfolio risk) to capture convex upside; fund ~30–50% of the premium by selling 3‑month put spreads on MSFT (buy 5% OTM puts, sell 15% OTM puts) to hedge the AI‑capex slowdown scenario.
• Implement a pair trade: long SMR equity or LEAPS + short a smaller notional (50% sizing) MSFT or NVDA 3–6 month put spread to offset headline capex downside; unwind if MSFT/NVDA implied volatility drops >30% or if SMR breaks above $28 (BofA PT) on volume.
• Reallocate 3–5% from high‑multiple AI‑infrastructure exposures (MSFT, NVDA) into uranium/commodity suppliers and industrial EPC names; increase monitoring cadence to weekly and exit or cut SMR exposure by 50% if no firm federal/TVA orders are in place by Dec 31, 2027.